Yes, but it will help doctors, not replace them
I’ve now treated several patients with the new cancer gene therapy called CAR-T, but there’s still a lot to learn
A prominent oncologist urges continuous testing of everyone from birth onward with implanted devices that detect cancerous cells before they spread
The drug targets the connection between the brain and the microbiome
Treatment first used in the early 20th century is showing promise against deadly infections
The finding that the virus causes “immune amnesia” further highlights the importance of vaccination
The popular heartburn drug may produce potentially unsafe levels of NDMA when its active ingredient breaks down
It could be the second human disease we eradicate—but if we don’t finish the job, resurgence is possible
The decision contradicts an earlier one to halt studies of the therapy, which followed a series of failed drugs that targeted diseased brain protein
Researchers measured a predictive increase in transfer RNA in people with epilepsy
A small study tested the approach for treating a common bacterial infection by restoring a healthy microbiome
William Kaelin, Jr., Peter Ratcliffe and Gregg Semenza share the 2019 Nobel Prize in Physiology or Medicine “for their discoveries of how cells sense and adapt to oxygen availability.” New therapies for cancer and conditions such as anemia are in the pipeline, based on these discoveries...
Research by William Kaelin, Jr., Peter Ratcliffe and Gregg Semenza led the way for applications in treating anemia, cancer and other diseases
The 2019 Nobel Prize in Physiology or Medicine goes to William G. Kaelin, Jr., Peter J. Ratcliffe and Gregg L. Semenza “for their discoveries of how cells sense and adapt to oxygen availability.” They identified molecular machinery that regulates gene activity in response to changing levels of oxygen...
The strains chosen for the Southern Hemisphere vaccine suggest the Northern Hemisphere one may not provide optimal protection
Approaches for boosting the body’s immune system are being tried for autoimmune and heart conditions, but it is too early to know how well they will work in people
From tree bark to digital therapies — USP has been safeguarding therapeutics for 200 years and is anticipating the next big medical breakthroughs.
Some forms of the drug ranitidine—including Zantac—have been shown to contain low levels of NDMA, which causes cancer in rats
A better understanding of the immune response to influenza is driving progress towards vaccines that protect against both seasonal and pandemic flu strains.
Rapid molecular tests for influenza are as quick as older on-the-spot tests and much more accurate. But that might not be enough to drive widespread adoption.